Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) is surging in pre-open action after the company announced that the FDA has agreed that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE